Representative(s): ENHERTU Booth:
Kristy Cooper
krcooper@dsi.com
651-303-8324 Joann Corazzelli
jcorazzelli@dsi.com
630-673-6709 Injectafer Booth:
Rob Rohloff
Oncology Territory Manager
rrohloff@dsi.com 414-899-7381 Jill Budnik
Sr Oncology Territory Manager
jbudnik@dsi.com/
414-218-5436 | Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.
With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. | ENHERTU website link
www.her2mbctreatmenthcp.com Patient Branded Brochure
 PP-US-ENB-0137_ENHERTU Patient Branded Brochure Downloadable PDF Label Update.pdf Breast Digital Branded Infusion Guide
PP-US-ENB-0176_ENHERTU Breast Digital Branded Infusion Guide Downloadable PDF Label Update (1).pdf Breast ISI Conventions Panel
PP-US-ENB-0545 ENHERTU Breast ISI Conventions Panel.pdf HCP PI Conventions Panel (Gastric-Breast)
PP-US-EN-0736 HCP PI Conventions Panel (Gastric-Breast).pdf |
